$3.08 Billion is the total value of Tekla Capital Management LLC's 189 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 6.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Buy | Unitedhealth Group Inc. | $126,358,000 | +60.0% | 315,548 | +48.6% | 4.11% | +51.1% |
| AMGN | Buy | Amgen Inc. | $112,955,000 | +9.0% | 463,405 | +11.2% | 3.67% | +3.0% |
| GILD | Sell | Gilead Sciences, Inc. | $112,571,000 | -4.1% | 1,634,785 | -10.0% | 3.66% | -9.4% |
| MRNA | Sell | Moderna, Inc. | $109,448,000 | +77.0% | 465,777 | -1.4% | 3.56% | +67.2% |
| ILMN | Sell | Illumina, Inc. | $95,498,000 | +0.8% | 201,809 | -18.2% | 3.10% | -4.8% |
| HZNP | Buy | Horizon Therapeutics plcshares | $87,679,000 | +17.5% | 936,340 | +15.5% | 2.85% | +11.0% |
| ABT | Buy | Abbott Laboratories | $87,063,000 | -2.3% | 750,997 | +1.0% | 2.83% | -7.7% |
| JNJ | Sell | Johnson & Johnson | $85,113,000 | -14.4% | 516,652 | -14.6% | 2.77% | -19.1% |
| VRTX | Vertex Pharmaceuticals Inc. | $79,702,000 | -6.2% | 395,288 | 0.0% | 2.59% | -11.4% | |
| REGN | Sell | Regeneron Pharmaceuticals, Inc. | $77,152,000 | +6.2% | 138,132 | -10.0% | 2.51% | +0.4% |
| BIIB | Sell | Biogen Inc. | $72,413,000 | +4.9% | 209,124 | -15.3% | 2.35% | -0.9% |
| TMO | Buy | Thermo Fisher Scientific Inc. | $70,691,000 | +36.3% | 140,130 | +23.3% | 2.30% | +28.8% |
| ABBV | Sell | AbbVie Inc. | $69,533,000 | +3.7% | 617,303 | -0.4% | 2.26% | -2.0% |
| MDT | Buy | Medtronic Plcshares | $67,865,000 | +16.7% | 546,722 | +11.1% | 2.20% | +10.2% |
| LLY | Sell | Eli Lilly and Co. | $58,886,000 | +7.9% | 256,561 | -12.2% | 1.91% | +2.0% |
| CI | Buy | Cigna Corp. | $50,026,000 | +9.0% | 211,018 | +11.1% | 1.63% | +3.0% |
| DHR | Sell | Danaher Corp. | $44,612,000 | +3.6% | 166,240 | -13.1% | 1.45% | -2.1% |
| BMY | Sell | Bristol-Myers Squibb Co. | $43,832,000 | -22.2% | 655,973 | -26.5% | 1.42% | -26.5% |
| MRK | Merck & Co., Inc. | $42,128,000 | +0.9% | 541,703 | 0.0% | 1.37% | -4.7% | |
| ANTM | Sell | Anthem, Inc. | $41,133,000 | -30.5% | 107,734 | -34.6% | 1.34% | -34.3% |
| SYK | Sell | Stryker Corp. | $39,089,000 | +5.7% | 150,500 | -0.9% | 1.27% | -0.2% |
| ZBH | Buy | Zimmer Biomet Holdings, Inc. | $35,815,000 | +7.7% | 222,703 | +7.2% | 1.16% | +1.7% |
| DXCM | Buy | Dexcom, Inc. | $35,336,000 | +31.7% | 82,755 | +10.9% | 1.15% | +24.4% |
| RMD | Buy | ResMed Inc. | $33,972,000 | +32.3% | 137,807 | +4.1% | 1.10% | +25.0% |
| SGEN | Sell | Seagen Inc. | $33,275,000 | +6.3% | 210,759 | -6.5% | 1.08% | +0.4% |
| MCK | Buy | McKesson Corp. | $28,823,000 | +17.3% | 150,715 | +19.7% | 0.94% | +10.9% |
| AZN | Buy | AstraZeneca PLCsponsored adr | $26,853,000 | +56.9% | 448,298 | +30.2% | 0.87% | +48.2% |
| CRSP | Buy | CRISPR Therapeutics AGnamen akt | $26,281,000 | +42.9% | 162,337 | +7.5% | 0.85% | +34.9% |
| HCA | Sell | HCA Healthcare, Inc. | $25,789,000 | -10.4% | 124,743 | -18.4% | 0.84% | -15.4% |
| HUM | Buy | Humana Inc. | $25,738,000 | +64.4% | 58,135 | +55.7% | 0.84% | +55.1% |
| UTHR | Buy | United Therapeutics Corp.class b | $25,017,000 | +135.5% | 139,438 | +119.5% | 0.81% | +122.7% |
| EXAS | Buy | Exact Sciences Corp. | $24,819,000 | +12.6% | 199,654 | +19.3% | 0.81% | +6.5% |
| XRAY | Buy | DENTSPLY SIRONA Inc. | $24,187,000 | +7.9% | 382,344 | +8.8% | 0.79% | +1.9% |
| XLV | Buy | Health Care Select Sector SPDR Fundsbi healthcare | $23,796,000 | +1926.9% | 188,930 | +1779.0% | 0.77% | +1832.5% |
| EW | Sell | Edwards Lifesciences Corp. | $22,946,000 | +14.9% | 221,555 | -7.2% | 0.75% | +8.6% |
| ALNY | Sell | Alnylam Pharmaceuticals, Inc. | $22,800,000 | +4.2% | 134,495 | -13.2% | 0.74% | -1.5% |
| ARGX | Buy | argenx SEsponsored adr | $22,403,000 | +26.4% | 74,410 | +15.6% | 0.73% | +19.3% |
| IDXX | IDEXX Laboratories, Inc. | $21,987,000 | +29.1% | 34,814 | 0.0% | 0.71% | +21.8% | |
| SYNH | Sell | Syneos Health, Inc.class a | $21,803,000 | +5.4% | 243,633 | -10.6% | 0.71% | -0.3% |
| NBIX | Neurocrine Biosciences, Inc. | $20,719,000 | +0.1% | 212,891 | 0.0% | 0.67% | -5.5% | |
| CRL | Buy | Charles River Laboratories International, Inc. | $20,225,000 | +62.0% | 54,674 | +26.9% | 0.66% | +53.1% |
| ASND | Buy | Ascendis Pharma A/Ssponsored adr | $20,211,000 | +32.5% | 153,636 | +29.8% | 0.66% | +25.1% |
| GH | Guardant Health, Inc. | $19,712,000 | -18.6% | 158,727 | 0.0% | 0.64% | -23.0% | |
| ISRG | Intuitive Surgical, Inc. | $19,585,000 | +24.5% | 21,296 | 0.0% | 0.64% | +17.6% | |
| LH | Sell | Laboratory Corp. of America Holdingssponsored adr | $19,413,000 | -23.6% | 70,374 | -29.3% | 0.63% | -27.8% |
| NVAX | Sell | Novavax, Inc. | $18,598,000 | -2.5% | 87,596 | -16.7% | 0.60% | -7.9% |
| PFE | Sell | Pfizer Inc. | $17,637,000 | -31.0% | 450,379 | -36.1% | 0.57% | -34.8% |
| WELL | Welltower Inc. | $16,876,000 | +16.0% | 203,083 | 0.0% | 0.55% | +9.6% | |
| WAT | Sell | Waters Corp. | $16,695,000 | -42.8% | 48,306 | -53.0% | 0.54% | -45.9% |
| MOH | Buy | Molina Healthcare, Inc. | $16,097,000 | +73.2% | 63,610 | +59.9% | 0.52% | +63.4% |
| BGNE | Buy | BeiGene, Ltd.sponsored adr | $15,781,000 | +12.2% | 45,983 | +13.9% | 0.51% | +6.0% |
| SRPT | Buy | Sarepta Therapeutics, Inc. | $15,021,000 | +56.3% | 193,224 | +49.8% | 0.49% | +47.4% |
| ADPT | Adaptive Biotechnologies Corp. | $13,799,000 | +1.5% | 337,722 | 0.0% | 0.45% | -4.3% | |
| IQV | Sell | IQVIA Holdings Inc. | $13,756,000 | +1.9% | 56,766 | -18.8% | 0.45% | -3.7% |
| GTHX | Buy | G1 Therapeutics, Inc. | $13,699,000 | +45.3% | 624,369 | +59.4% | 0.44% | +37.3% |
| IMAB | Sell | I-Mabsponsored ads | $13,649,000 | +68.7% | 162,580 | -2.6% | 0.44% | +59.7% |
| MTD | Mettler-Toledo International Inc. | $13,576,000 | +19.9% | 9,800 | 0.0% | 0.44% | +13.1% | |
| MRTX | Mirati Therapeutics, Inc. | $13,534,000 | -5.7% | 83,784 | 0.0% | 0.44% | -10.9% | |
| ARNA | Arena Pharmaceuticals, Inc. | $13,393,000 | -1.7% | 196,385 | 0.0% | 0.44% | -7.2% | |
| IONS | Buy | Ionis Pharmaceuticals, Inc. | $12,865,000 | +32.2% | 322,521 | +49.1% | 0.42% | +24.8% |
| RARE | Buy | Ultragenyx Pharmaceutical Inc. | $12,833,000 | +15.6% | 134,590 | +38.1% | 0.42% | +9.2% |
| BNTX | Sell | BioNTech SEsponsored ads | $12,778,000 | +70.1% | 57,073 | -17.1% | 0.42% | +60.9% |
| NVS | Novartis AGsponsored adr | $12,429,000 | +6.7% | 136,225 | 0.0% | 0.40% | +0.7% | |
| CVS | Sell | CVS Health Corp. | $12,303,000 | -25.7% | 147,453 | -33.0% | 0.40% | -29.7% |
| IOVA | Sell | Iovance Biotherapeutics, Inc. | $12,191,000 | -26.0% | 468,538 | -10.0% | 0.40% | -30.2% |
| JAZZ | Jazz Pharmaceuticals plcshares | $11,983,000 | +8.1% | 67,456 | 0.0% | 0.39% | +2.1% | |
| VTR | Ventas, Inc. | $11,883,000 | +7.1% | 208,108 | 0.0% | 0.39% | +1.0% | |
| ALXN | Sell | Alexion Pharmaceuticals, Inc. | $11,841,000 | -30.0% | 64,453 | -41.8% | 0.38% | -33.8% |
| AMED | Buy | Amedisys, Inc. | $11,774,000 | +129.2% | 48,070 | +147.8% | 0.38% | +116.4% |
| DNLI | Denali Therapeutics Inc. | $11,773,000 | +37.4% | 150,086 | 0.0% | 0.38% | +29.8% | |
| BBIO | Buy | BridgeBio Pharma, Inc. | $11,507,000 | +150.0% | 188,767 | +152.7% | 0.37% | +136.7% |
| KRTX | Buy | Karuna Therapeutics, Inc. | $11,451,000 | +11.7% | 100,458 | +17.9% | 0.37% | +5.4% |
| ALLK | Sell | Allakos Inc. | $11,358,000 | -39.5% | 133,045 | -18.7% | 0.37% | -42.9% |
| OMI | Owens & Minor, Inc. | $11,261,000 | +12.6% | 266,023 | 0.0% | 0.37% | +6.4% | |
| DCPH | Deciphera Pharmaceuticals, Inc. | $11,265,000 | -18.4% | 307,703 | 0.0% | 0.37% | -22.9% | |
| OHI | Omega Healthcare Investors, Inc. | $11,120,000 | -0.9% | 306,433 | 0.0% | 0.36% | -6.5% | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $11,006,000 | +24.9% | 132,886 | 0.0% | 0.36% | +18.2% | |
| BPMC | Blueprint Medicines Corp. | $10,793,000 | -9.5% | 122,699 | 0.0% | 0.35% | -14.4% | |
| BMRN | BioMarin Pharmaceutical Inc. | $10,681,000 | +10.5% | 128,004 | 0.0% | 0.35% | +4.5% | |
| BDX | Becton, Dickinson and Co. | $10,532,000 | +0.0% | 43,307 | 0.0% | 0.34% | -5.5% | |
| ZTS | Zoetis Inc.class a | $10,533,000 | +18.3% | 56,521 | 0.0% | 0.34% | +11.8% | |
| GRTX | Galera Therapeutics, Inc. | $10,241,000 | +11.4% | 1,041,845 | 0.0% | 0.33% | +5.4% | |
| APLS | Apellis Pharmaceuticals, Inc. | $9,640,000 | +47.3% | 152,538 | 0.0% | 0.31% | +39.1% | |
| TBPH | Buy | Theravance Biopharma, Inc. | $9,529,000 | +2.3% | 656,296 | +43.8% | 0.31% | -3.1% |
| NTLA | Buy | Intellia Therapeutics, Inc. | $9,420,000 | +120.7% | 58,180 | +9.4% | 0.31% | +108.2% |
| TPTX | Turning Point Therapeutics, Inc. | $9,310,000 | -17.5% | 119,324 | 0.0% | 0.30% | -21.9% | |
| SBRA | Sabra Health Care REIT, Inc. | $9,294,000 | +4.8% | 510,660 | 0.0% | 0.30% | -1.0% | |
| DOC | Physicians Realty Trust | $9,156,000 | +4.5% | 495,733 | 0.0% | 0.30% | -1.0% | |
| EXEL | Sell | Exelixis, Inc. | $9,104,000 | -63.4% | 499,657 | -54.6% | 0.30% | -65.4% |
| INCY | Incyte Corp. | $9,060,000 | +3.5% | 107,687 | 0.0% | 0.29% | -2.3% | |
| UHS | Sell | Universal Health Services, Inc.class b | $8,789,000 | -7.6% | 60,023 | -15.8% | 0.29% | -12.5% |
| CTLT | Catalent, Inc. | $8,652,000 | +2.7% | 80,025 | 0.0% | 0.28% | -3.1% | |
| REPL | Replimune Group, Inc. | $8,416,000 | +25.9% | 219,060 | 0.0% | 0.27% | +18.7% | |
| ITCI | Sell | Intra-Cellular Therapies, Inc. | $8,276,000 | +4.9% | 202,756 | -12.8% | 0.27% | -0.7% |
| MPW | Medical Properties Trust, Inc. | $8,276,000 | -5.5% | 411,743 | 0.0% | 0.27% | -10.6% | |
| ACAD | ACADIA Pharmaceuticals Inc. | $8,092,000 | -5.5% | 331,789 | 0.0% | 0.26% | -10.5% | |
| BSX | Boston Scientific Corp. | $7,950,000 | +10.6% | 185,931 | 0.0% | 0.26% | +4.5% | |
| A | Agilent Technologies, Inc. | $7,764,000 | +16.3% | 52,525 | 0.0% | 0.25% | +9.6% | |
| AFMD | Buy | Affimed N.V. | $7,724,000 | +239.1% | 908,736 | +215.5% | 0.25% | +221.8% |
| ICLR | Buy | Icon plcshares | $7,515,000 | +62.2% | 36,357 | +54.1% | 0.24% | +53.5% |
| STRO | Sell | Sutro Biopharma, Inc. | $7,439,000 | -43.0% | 400,147 | -30.3% | 0.24% | -46.1% |
| LTC | LTC Properties, Inc. | $6,998,000 | -8.0% | 182,293 | 0.0% | 0.23% | -13.4% | |
| QURE | Buy | uniQure N.V.shares | $6,958,000 | +65.2% | 225,921 | +80.7% | 0.23% | +55.9% |
| YMAB | Y-mAbs Therapeutics, Inc. | $6,686,000 | +11.8% | 197,820 | 0.0% | 0.22% | +5.3% | |
| ZLAB | Zai Lab Ltd.adr | $6,641,000 | +32.6% | 37,523 | 0.0% | 0.22% | +25.6% | |
| ARVN | Arvinas, Inc. | $6,622,000 | +16.5% | 85,997 | 0.0% | 0.22% | +9.7% | |
| SAGE | Sage Therapeutics, Inc. | $6,483,000 | -24.1% | 114,119 | 0.0% | 0.21% | -28.2% | |
| FATE | Sell | Fate Therapeutics, Inc. | $6,312,000 | -49.1% | 72,727 | -51.6% | 0.20% | -51.9% |
| ALGN | Align Technology, Inc. | $6,064,000 | +12.8% | 9,925 | 0.0% | 0.20% | +6.5% | |
| FOLD | Amicus Therapeutics, Inc. | $5,993,000 | -2.4% | 621,659 | 0.0% | 0.20% | -7.6% | |
| TEVA | Sell | Teva Pharmaceutical Industries Ltd.sponsored adr | $6,016,000 | -21.1% | 607,651 | -8.0% | 0.20% | -25.6% |
| PKI | PerkinElmer, Inc. | $5,728,000 | +20.4% | 37,094 | 0.0% | 0.19% | +13.4% | |
| STE | Sell | STERIS plcshares | $5,705,000 | -76.4% | 27,655 | -78.2% | 0.18% | -77.7% |
| KURA | Kura Oncology, Inc. | $5,702,000 | -26.2% | 273,463 | 0.0% | 0.18% | -30.5% | |
| RETA | Reata Pharmaceuticals, Inc.class a | $5,409,000 | +42.0% | 38,219 | 0.0% | 0.18% | +34.4% | |
| AUPH | Aurinia Pharmaceuticals Inc. | $5,157,000 | -0.2% | 397,920 | 0.0% | 0.17% | -5.6% | |
| Trillium Therapeutics Inc. | $5,133,000 | -9.7% | 529,226 | 0.0% | 0.17% | -14.8% | ||
| PEAK | Healthpeak Properties, Inc. | $5,007,000 | +4.9% | 150,392 | 0.0% | 0.16% | -0.6% | |
| VRNA | Verona Pharma plcsponsored adr | $4,917,000 | -21.8% | 751,905 | 0.0% | 0.16% | -25.9% | |
| CNC | Centene Corp. | $4,907,000 | +14.1% | 67,290 | 0.0% | 0.16% | +7.4% | |
| ADUS | Buy | Addus HomeCare Corp. | $4,732,000 | +20.2% | 54,237 | +44.1% | 0.15% | +14.1% |
| SNN | Buy | Smith & Nephew plcshares | $4,677,000 | +24.0% | 107,670 | +8.1% | 0.15% | +16.9% |
| PSNL | Personalis, Inc. | $4,547,000 | +2.8% | 179,731 | 0.0% | 0.15% | -2.6% | |
| RCM | Buy | R1 RCM Inc. | $4,500,000 | +47.7% | 202,351 | +63.9% | 0.15% | +39.0% |
| COGT | Cogent Biosciences, Inc. | $4,361,000 | -7.6% | 537,742 | 0.0% | 0.14% | -12.3% | |
| SNY | Sanofisponsored adr | $4,295,000 | +6.5% | 81,554 | 0.0% | 0.14% | +0.7% | |
| PRAH | Sell | PRA Health Sciences, Inc. | $4,141,000 | -74.0% | 25,068 | -75.9% | 0.14% | -75.4% |
| ARDX | Sell | Ardelyx, Inc. | $4,089,000 | +1.6% | 539,408 | -11.2% | 0.13% | -3.6% |
| NVO | Novo Nordisk A/Ssponsored adr | $4,055,000 | +24.2% | 48,406 | 0.0% | 0.13% | +17.9% | |
| TCRR | TCR2 Therapeutics Inc. | $3,870,000 | -25.7% | 235,808 | 0.0% | 0.13% | -29.6% | |
| VIR | Vir Biotechnology, Inc. | $3,849,000 | -7.8% | 81,400 | 0.0% | 0.12% | -13.2% | |
| FMTX | Forma Therapeutics Holdings, Inc.shares | $3,729,000 | -11.2% | 149,825 | 0.0% | 0.12% | -16.0% | |
| ARQT | Arcutis Biotherapeutics, Inc. | $3,592,000 | -5.7% | 131,633 | 0.0% | 0.12% | -10.7% | |
| TAK | Takeda Pharmaceutical Company Ltd.sponsored ads | $3,537,000 | -7.8% | 210,146 | 0.0% | 0.12% | -12.9% | |
| TECH | Bio-Techne Corp. | $3,422,000 | +17.9% | 7,600 | 0.0% | 0.11% | +11.0% | |
| MEDP | Medpace Holdings, Inc. | $3,333,000 | +7.7% | 18,871 | 0.0% | 0.11% | +1.9% | |
| MREO | Buy | Mereo BioPharma Group plcads | $3,312,000 | -1.5% | 1,044,790 | +4.8% | 0.11% | -6.9% |
| HR | Healthcare Realty Trust Inc. | $3,142,000 | -0.4% | 104,024 | 0.0% | 0.10% | -5.6% | |
| XENE | Buy | Xenon Pharmaceuticals Inc. | $3,147,000 | +6.0% | 169,030 | +1.9% | 0.10% | 0.0% |
| SRRK | Buy | Scholar Rock Holding Corp. | $3,145,000 | +29.7% | 108,833 | +127.4% | 0.10% | +22.9% |
| NKTR | Nektar Therapeutics | $3,096,000 | -14.2% | 180,438 | 0.0% | 0.10% | -18.5% | |
| TVTX | Travere Therapeutics, Inc. | $3,106,000 | -41.6% | 212,869 | 0.0% | 0.10% | -44.8% | |
| BCEL | Atreca, Inc. | $3,003,000 | -44.4% | 352,424 | 0.0% | 0.10% | -47.3% | |
| PHG | Koninklijke Philips N.V.ny reg sh | $2,829,000 | -12.9% | 56,927 | 0.0% | 0.09% | -17.9% | |
| INSM | Insmed Inc. | $2,800,000 | -16.4% | 98,387 | 0.0% | 0.09% | -20.9% | |
| JNCE | Jounce Therapeutics, Inc. | $2,599,000 | -33.8% | 382,237 | 0.0% | 0.08% | -37.8% | |
| GMRE | Global Medical REIT Inc. | $2,581,000 | +12.6% | 174,897 | 0.0% | 0.08% | +6.3% | |
| HLXA | Helix Acquisition Corp. | $2,583,000 | +0.9% | 250,000 | 0.0% | 0.08% | -4.5% | |
| DRNA | Dicerna Pharmaceuticals, Inc. | $2,543,000 | +45.9% | 68,150 | 0.0% | 0.08% | +38.3% | |
| ENDP | Endo International plcshares | $2,488,000 | -36.8% | 531,570 | 0.0% | 0.08% | -40.0% | |
| KALV | Buy | KalVista Pharmaceuticals, Inc. | $2,396,000 | +86.5% | 100,000 | +100.0% | 0.08% | +77.3% |
| PRGO | Perrigo Co. plcshares | $2,349,000 | +13.3% | 51,224 | 0.0% | 0.08% | +7.0% | |
| SNR | New Senior Investment Group Inc. | $2,251,000 | +41.0% | 256,398 | 0.0% | 0.07% | +32.7% | |
| HOLX | Hologic, Inc. | $2,173,000 | -10.3% | 32,564 | 0.0% | 0.07% | -14.5% | |
| HTA | Healthcare Trust of America, Inc. | $1,887,000 | -3.2% | 70,662 | 0.0% | 0.06% | -9.0% | |
| VECT | New | Vectivbio Holding AGord shares | $1,691,000 | – | 145,000 | +100.0% | 0.06% | – |
| OGN | New | Organon & Co. | $1,639,000 | – | 54,169 | +100.0% | 0.05% | – |
| BDTX | Black Diamond Therapeutics, Inc. | $1,609,000 | -49.8% | 131,990 | 0.0% | 0.05% | -52.7% | |
| CYH | Sell | Community Health Systems, Inc. | $1,568,000 | -1.3% | 101,535 | -13.6% | 0.05% | -7.3% |
| MOR | MorphoSys AGsponsored ads | $1,576,000 | -11.7% | 81,867 | 0.0% | 0.05% | -16.4% | |
| MTEM | Molecular Templates, Inc. | $1,559,000 | -38.1% | 199,420 | 0.0% | 0.05% | -41.4% | |
| ICPT | Intercept Pharmaceuticals, Inc. | $1,539,000 | -13.5% | 77,067 | 0.0% | 0.05% | -18.0% | |
| ZGNX | Zogenix, Inc. | $1,538,000 | -11.5% | 88,977 | 0.0% | 0.05% | -16.7% | |
| DHC | Diversified Healthcare Trust | $1,495,000 | -12.6% | 357,720 | 0.0% | 0.05% | -16.9% | |
| OVID | Ovid Therapeutics Inc.sponsored adr | $1,457,000 | -2.7% | 372,733 | 0.0% | 0.05% | -9.6% | |
| PRAX | Praxis Precision Medicines, Inc. | $1,371,000 | -44.2% | 75,000 | 0.0% | 0.04% | -47.1% | |
| MDGL | Madrigal Pharmaceuticals, Inc. | $1,299,000 | -16.7% | 13,340 | 0.0% | 0.04% | -22.2% | |
| ONEM | 1Life Healthcare, Inc. | $1,034,000 | -15.4% | 31,266 | 0.0% | 0.03% | -19.0% | |
| CCXI | Sell | ChemoCentryx, Inc. | $1,047,000 | -85.9% | 78,197 | -45.9% | 0.03% | -86.7% |
| NKTX | Nkarta, Inc. | $919,000 | -3.7% | 28,988 | 0.0% | 0.03% | -9.1% | |
| TFX | Teleflex Inc. | $884,000 | -3.3% | 2,200 | 0.0% | 0.03% | -6.5% | |
| EDIT | Editas Medicine, Inc. | $860,000 | +34.8% | 15,190 | 0.0% | 0.03% | +27.3% | |
| RGNX | REGENXBIO Inc. | $843,000 | +13.9% | 21,700 | 0.0% | 0.03% | +8.0% | |
| GRFS | Grifols, S.A.sponsored adr | $822,000 | +0.4% | 47,373 | 0.0% | 0.03% | -3.6% | |
| DTIL | Precision BioSciences, Inc. | $789,000 | +21.0% | 63,001 | 0.0% | 0.03% | +18.2% | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $757,000 | -7.1% | 413,481 | 0.0% | 0.02% | -10.7% | |
| GMDA | Gamida Cell Ltd.shares | $757,000 | -20.8% | 118,142 | 0.0% | 0.02% | -24.2% | |
| UHT | Universal Health Realty Income Trustshares | $693,000 | -9.2% | 11,258 | 0.0% | 0.02% | -11.5% | |
| CHCT | Community Healthcare Trust Inc. | $707,000 | +2.9% | 14,900 | 0.0% | 0.02% | -4.2% | |
| NHI | National Health Investors, Inc. | $673,000 | -7.3% | 10,038 | 0.0% | 0.02% | -12.0% | |
| ASRT | New | Assertio Holdings, Inc. | $640,000 | – | 410,575 | +100.0% | 0.02% | – |
| VYNE | VYNE Therapeutics Inc. | $475,000 | -48.8% | 135,395 | 0.0% | 0.02% | -53.1% | |
| SPPI | Spectrum Pharmaceuticals, Inc. | $430,000 | +15.0% | 114,670 | 0.0% | 0.01% | +7.7% | |
| CBAY | CymaBay Therapeutics, Inc. | $384,000 | -4.0% | 88,102 | 0.0% | 0.01% | -14.3% | |
| CLDX | Celldex Therapeutics, Inc. | $236,000 | +62.8% | 7,053 | 0.0% | 0.01% | +60.0% | |
| FVE | Five Star Senior Living Inc. | $140,000 | -5.4% | 24,237 | 0.0% | 0.01% | 0.0% | |
| ABIO | ARCA biopharma, Inc. | $113,000 | -4.2% | 32,461 | 0.0% | 0.00% | 0.0% | |
| Bellicum Pharmaceuticals, Inc. | $20,000 | -13.0% | 6,000 | 0.0% | 0.00% | 0.0% | ||
| Tetraphase Pharmaceuticals, Inc. | $5,000 | -44.4% | 42,965 | 0.0% | 0.00% | – | ||
| CLLS | Exit | Cellectissponsored adr | $0 | – | -11,955 | -100.0% | -0.01% | – |
| CLSD | Exit | Clearside Biomedical, Inc. | $0 | – | -165,330 | -100.0% | -0.01% | – |
| ASRT | Exit | Assertio Holdings, Inc. | $0 | – | -1,642,302 | -100.0% | -0.04% | – |
| HRTX | Exit | Heron Therapeutics, Inc. | $0 | – | -131,183 | -100.0% | -0.07% | – |
| GMAB | Exit | Genmab A/Ssponsored ads | $0 | – | -73,015 | -100.0% | -0.08% | – |
| PIRS | Exit | Pieris Pharmaceuticals, Inc. | $0 | – | -1,023,348 | -100.0% | -0.09% | – |
| THC | Exit | Tenet Healthcare Corp. | $0 | – | -60,336 | -100.0% | -0.11% | – |
| ALKS | Exit | Alkermes plcshares | $0 | – | -169,930 | -100.0% | -0.11% | – |
| TDOC | Exit | Teladoc Health, Inc. | $0 | – | -29,664 | -100.0% | -0.18% | – |
| MORF | Exit | Morphic Holding, Inc. | $0 | – | -89,559 | -100.0% | -0.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.